Shingles vaccine effective in immunosuppressed patients with inflammatory myopathies

More than 80% of immunosuppressed patients with idiopathic inflammatory myopathy achieved seroconversion after receiving the recombinant zoster vaccine, according to data published in Arthritis Care & Research. “Although [the recombinant zoster vaccine (RZV)] has shown an overall favorable safety profile in patients with [autoimmune rheumatic diseases (ARDs)], concerns persist regarding